Molecular Microbiology Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Department of Food Quality and Safety, Institute for Postharvest and Food Sciences, The Volcani Center, Agricultural Research Organization, Rishon LeZion, Israel.
Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.01751-17. Print 2018 Apr.
and species complexes are the etiologic agents of cryptococcosis. We have deciphered the roles of three ABC transporters, Afr1, Afr2, and Mdr1, in the representative strains of the two species, H99 and R265. Deletion of in H99 and R265 drastically reduced the levels of resistance to three xenobiotics and three triazoles, suggesting that Afr1 is the major drug efflux pump in both strains. Fluconazole susceptibility was not affected when or was deleted in both strains. However, when these genes were deleted in combination with , a minor additive effect in susceptibility toward several drugs was observed. Deletion of all three genes in both strains caused further increases in susceptibility toward fluconazole and itraconazole, suggesting that Afr2 and Mdr1 augment Afr1 function in pumping these triazoles. Intracellular accumulation of Nile Red significantly increased in mutants of both strains, but rhodamine 6G accumulation increased only in the mutant of H99. Thus, the three efflux pumps play different roles in the two strains when exposed to different azoles and xenobiotics. and expression was upregulated in H99 and R265 when treated with fluconazole. However, expression was upregulated only in R265 under the same conditions. We screened a library of transcription factor mutants and identified several mutants that manifested either altered fluconazole sensitivity or an increase in the frequency of fluconazole heteroresistance. Gene expression analysis suggests that the three efflux pumps are regulated independently by different transcription factors in response to fluconazole exposure.
和 种复合体是隐球菌病的病原体。我们已经揭示了三个 ABC 转运蛋白 Afr1、Afr2 和 Mdr1 在两个代表菌株 H99 和 R265 中的作用。在 H99 和 R265 中缺失 显著降低了对三种外源性物质和三种三唑类药物的耐药水平,表明 Afr1 是这两种菌株中主要的药物外排泵。当在两种菌株中缺失 或 时,氟康唑的敏感性不受影响。然而,当这些基因与 缺失组合时,观察到对几种药物的敏感性存在轻微的附加效应。在两种菌株中缺失所有三个基因导致对氟康唑和伊曲康唑的敏感性进一步增加,表明 Afr2 和 Mdr1 增强了 Afr1 对这些三唑类药物的泵出功能。两种菌株的 突变体中尼罗红的细胞内积累显著增加,但 H99 的 突变体中罗丹明 6G 的积累仅增加。因此,当暴露于不同的唑类和外源性物质时,这三个外排泵在两种菌株中发挥不同的作用。在 H99 和 R265 中用氟康唑处理时, 和 表达上调。然而,在相同条件下,仅在 R265 中上调 表达。我们筛选了转录因子突变体文库,并鉴定出几个突变体,这些突变体表现出改变的氟康唑敏感性或氟康唑异质性耐药性增加的频率。基因表达分析表明,这三个外排泵在响应氟康唑暴露时由不同的转录因子独立调节。